1st aseica educational symposium - tacticsmd.net

Organized by:

www.aseica.es

1 st ASEICA EDUCATIONAL

SYMPOSIUM

Madrid, 14th and 15th November 2017

#ASEICAEducationalSymposium

Venue: Aula Magna Facultad de Medicina,Universidad Autónoma de MadridC/Arzobispo Morcillo, 2-4, Madrid

SCIENTIFIC COORDINATION

Dr. Carlos CampsDr. Jesús ParamioDr. Rafael LópezDr. Arkaitz Carracedo

SCIENTIFIC COMMITTEE

Dr. Carlos Camps Dr. Xosé R. BusteloDra. Noemí Reguart Dr. Arkaitz Carracedo Dr. Jesús Paramio Dra. Angélica Figueroa Dr. José Palacios Dra. Gema Moreno Dra. Maria S. Soengas Dr. Héctor Peinado Dr. Rafael López

www.aseica.es

Tuesday, November 14th 2017

09:00 - 09:05 h WELCOME

09:05 - 10:00 h 1st SESSION: EPIGENOMIC AND CANCER Chairpersons: Dr. Jesús Paramio, Centro de Investigaciones Energéticas,

Medioambientales y Tecnológicas-CIEMAT, Madrid

Dr. Esteban Ballestar, Institut d’Investigació Biomèdica de

Bellvitge-IDIBELL, Barcelona

09:05 - 09:20 h Small molecules targeting epigenetic modulators for cancer treatment Dr. Xabier Aguirre, Centro de Investigación Médica Aplicada-CIMA,

Universidad de Navarra, Pamplona

09:20 - 09:35 h Transfer RNA methylation in cancer Dra. Sandra Blanco, CIC bioGUNE, Derio

09:35 - 09:40 h Oral communication Inhibition of a G9A-EZH2 network triggers an immune-mediated bladder cancer regression Dra. Cristina Segovia, Centro de Investigaciones Energéticas,

Medioambientales y Tecnológicas-CIEMAT, Madrid

09:40 - 09:45 h Oral communication Correlation between tumor history and microenvironment using multiregion single-molecule epigenomic data from colorectal cancer patients Dr. José Luis Soto, Universidad de Vigo

09:45 - 10:00 h Discussion

10:00 - 10:35 h EMERGING TOPICS IN CANCER: TUMOR EVOLUTION 10:00 - 10:05 h Chairperson: Dr. Pedro A. Lazo-Zbikowski, Centro de Investigación del Cáncer,

Universidad de Salamanca-CSIC

10:05 - 10:30 h Speaker: Dr. David Posada, Universidad de Vigo


10:35 - 11:10 h POSTER VIEWING, NETWORKING AND COFFEE BREAK3

1 st ASEICA EDUCATIONAL SYMPOSIUM


4




11:10 - 12:20 h 2nd SESSION: IMMUNOLOGY AND CANCER

Session supported by an educational grant

Chairpersons:

Dr. Ignacio Melero, Centro de Investigación Médica Aplicada-CIMA,


Dr. Luis Paz-Ares, Hospital Universitario 12 de Octubre, Madrid

11:10 - 11:25 h HLA class I loss and tumour immune escape Dr. Federico Garrido, Hospital Universitario Virgen de las Nieves, Granada

11:25 - 11:40 h Immunotherapy resistance modes: primary, adaptative and acquired Dr. Rafael Rosell, Hospital Universitari Germans Trias i Pujol-ICO, Badalona

11:40 - 11:55 h Microbiome and the modulation of the immune system Dr. Andrés Moya, Universidad de Valencia

11:55 - 12:00 h Oral communication The zebrafish: a new model to understand the crosstalk between inflammation and cancer Dr. Victoriano Mulero, Universidad de Murcia

12:00 - 12:05 h Oral communication Novel molecular mechanisms of immunoresistance and cancer stem cell activity Dr. Ander Sáenz, Instituto de Investigación Sanitaria Biodonostia, Donostia


12:20 - 12:40 h OFFICIAL OPENING

12:40 - 13:25 h RECENT ADVANCES IN BREAST CANCER


Chairpersons:

Dr. Javier Cortés, Hospital Universitario Ramón y Cajal, Madrid

Dr. Atanasio Pandiella, Centro de Investigación del Cáncer, Universidad

de Salamanca-CSIC

12:40 - 12:55 h Emerging therapeutic strategies Dra. Eva Ciruelos, Hospital Universitario 12 de Octubre, Madrid

5

12:55 - 13:10 h Research advances towards disease eradication Dr. Alberto Ocaña, Complejo Hospitalario Universitario de Albacete


13:25 - 14:25 h POSTER VIEWING, NETWORKING AND LUNCH

14:25 - 15:10 h RECENT ADVANCES IN LUNG CANCER

Session supported by an educational grant Chairpersons:

Dr. Mariano Provencio, Hospital Universitario Puerta del

Hierro-Majadahonda, Madrid

Dr. Rubén Pío, Centro de Investigación Médica Aplicada-CIMA,


14:25 - 14:40 h Emerging therapeutic strategies Dra. Pilar Garrido, Hospital Universitario Ramón y Cajal, Madrid

14:40 - 14:55 h Research advances towards disease eradication Dra. Montserrat Sánchez Céspedes, Institut d’Investigació Biòmedica

de Bellvitge-IDIBELL, Barcelona


15:10 - 15:55 h THE ASEICA FORUM. CURRENT STATUS OF RESEARCH IN SPAIN Chairpersons:

Dr. Carlos Camps, ASEICA President

Dra. Ruth Vera, SEOM President

15:10 - 15:25 h Speaker: Dr. Joaquín Arribas, CIBERONC Director

15:25 - 15:55 h Discussion:

Dr. Josep Tabernero, ESMO President Elect

Dr. José Palacios, SEAP President

Dr. Eduardo López-Collazo, IdiPAZ Scientific Director

Dr. José Mª Mato, CIC bioGUNE Director

Dr. Ángel Carracedo, Universidad de Santiago de Compostela

Dª. Isabel Orbe, Fundación Científica AECC Director

www.aseica.es


15:55 - 17:20 h 3rd SESSION: ASEICA - SEOM NOVEL THERAPEUTIC TARGETS AND APPROACHES FOR THE TREATMENT OF CANCER

Chairpersons:

Dr. Xosé R. Bustelo, ASEICA Vice-president

Dr. Álvaro Rodríguez Lescure, SEOM Vice-president

15:55 - 16:10 h Molecular insights to glioblastoma progression and therapy resistance Dr. Joan Seoane, ICREA-Vall d’Hebron Institut d’Oncologia, Barcelona

16:10 - 16:25 h Driver genes in hematological neoplasias: role of mutations in non-coding regions Dr. Xosé Puente, Universidad de Oviedo

16:25 - 16:40 h Clinically relevant novel drivers in glioblastoma Dr. Juan Manuel Sepúlveda, Hospital Universitario 12 de Octubre, Madrid

16:40 - 16:55 h Novel hallmarks of cancer Dr. Alberto Ocaña, Complejo Hospitalario Universitario de Albacete

16:55 - 17:00 h Oral communication Dissecting the contribution of the vesicle trafficking modulators RAB7 and RAB27 to melanoma progression and metastasis Dr. Rául Martínez, Centro Nacional de Investigaciones Oncológicas-CNIO,

Madrid

17:00 - 17:05 h Oral communication Novel therapeutic targets: aiming at VAV2 in Squamous Cell Carcinoma Dr. Luis Francisco Lorenzo, Centro de Investigación del Cáncer,

Universidad de Salamanca-CSIC


17:30 - 20:00 h CIBERONC MEETING

6




7

CIBERONCMEETING

17:30 – 17:45 Welcome Dr. Joaquín Arribas. Scientific Director of CIBERONCVall D’Hebron Instituto de Oncología

17:45 – 18:15Navigating uncharted waters in translational tumor immunotherapyDr. Ignacio Melero. Professor of Immunology at CIMA.

18:15 – 18:45Oncogenic control of metabolismDr. Arkaitz Carracedo. IKERBASQUE research Professor at CIC bioGUNE.

18:45 – 20:00 Programs UpdatesDr. Josep M. Tabernero. Coordinator of Gastrointestinal Tumors ProgramVall D’Hebron Instituto de Oncología (VHIO)

Dr. Atanasio Pandiella. Co-coordinator of Breast Cancer ProgramCentro de Investigación del Cáncer Universidad de Salamanca-CSIC

Dr. Luis Montuenga. Coordinator of Tumors of Respiratory Tract ProgramCentro para la Investigación Médica Aplicada (CIMA)

Dra. Dolors Colomer. Coordinator of Hematological Tumors ProgramInstituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS)

Dr. Enrique de Álava. Coordinator of Low Prevalence Tumors ProgramInstituto de Biomedicina de Sevilla (IBiS)

Dr. Xosé Bustelo. Coordinator of Mechanism of Tumor Progression ProgramCentro de Investigación del Cáncer Universidad de Salamanca-CSIC

Dra. Amparo Cano. Coordinator of Training and Mobility ProgramInstituto de Investigaciones Biomédicas Alberto Sols (IIB)

20:00 CIBERONC Networking Cocktail

NOVEMBER14th 2017

www.aseica.es

8

Wednesday, November 15th 2017

0 9:00 - 10:00 h ASEICA & CIBER CAREER PROSPECTS FOR CANCER RESEARCHERS IN TRAINING

Chairpersons: Dra. Amparo Cano, Instituto de Investigaciones Biomédicas

“Alberto Sols” CSIC-UAM, Madrid

Dra. María S. Soengas, Centro Nacional de Investigaciones

Oncológicas-CNIO, Madrid

09:00 - 09:15 h The importance of mentorship Dra. Ana Rio-Machin, CERU representative, London, UK

09:15 - 09:30 h Searching for a postdoctoral position Dr. Amancio Carnero, Instituto de Biomedicina de Sevilla. Campus

Hospital Universitario Virgen del Rocío

09:30 - 09:45 h Paving the way to a successful career in cancer research Dra. Angélica Figueroa, Instituto de Investigación Biomédica de

A Coruña-INIBIC

09:45 - 10:00 h Discussion: Dra. Gema Moreno, Universidad Autónoma de Madrid & MD Anderson

Cancer Center

Dra. Noemí Reguart, Institut d’Investigacions Biomèdiques August Pi i

Sunyer-IDIBAPS, Hospital Clínic de Barcelona

Dr. Guillermo Velasco, Universidad Complutense de Madrid

10:00 - 11:10 h 4th SESSION: LIQUID BIOPSY. CHASING CIRCULATING TRACES OF CANCER

Chairpersons:

Dr. Rafael López, Complejo Hospitalario Universitario de Santiago

Dra. Eloisa Jantus, Fundación Investigación Hospital General

Universitario de Valencia

10:00 - 10:15 h Current and future prospects of liquid biopsy Dra. Ana Vivancos, Hospital Universitari Vall d’Hebron, Barcelona



9

10:15 - 10:30 h Use of circulating exosomes as surrogate markers of tumours, the future of the liquid biopsy? Dr. Héctor Peinado, Centro Nacional de Investigaciones Oncológicas-CNIO, Madrid

10:30 - 10:45 h Alternative forms of liquid biopsy Dr. Miguel Abal, Instituto de Investigación Sanitaria de Santiago-IDIS/SERGAS,

Santiago de Compostela

10:45 - 10:50 h Oral communication Identification of potentially druggable mutations using the liquid biopsy in familial PDAC Dra. Julie Earl, Hospital Universitario Ramón y Cajal, Madrid

10:50 - 10:55 h Oral communication Clinical utility of plasma-based next-generation sequencing (NGS) for advanced NSCLC patients with insufficient or unavailable tumor tissue Dra. Eloisa Jantus, Fundación Investigación Hospital General Universitario

de Valencia


11:10 - 11:55 h POSTER VIEWING, NETWORKING AND COFFEE BREAK

11:55 - 13:10 h ASEICA DEBATES WITH THE EXPERT: CANCER-SPECIFIC CHALLENGES


Chairpersons:

Dr. Luis Montuenga, Centro de Investigación Médica Aplicada-CIMA,


Dr. Alfredo Carrato, Hospital Universitario Ramón y Cajal, Madrid

11:55 - 12:10 h Molecular classification in colon cancer Dr. Héctor García Palmer, Hospital Universitari Vall d’Hebron, Barcelona

12:10 - 12:25 h Why is pancreatic cancer so difficult to treat? Dr. Francisco X. Real, Centro Nacional de Investigaciones Oncológicas-CNIO, Madrid

12:25 - 12:40 h Exploiting genomic instability in ovarian and prostate cancer: PARP inhibitors Dr. Luis Manso, Hospital Universitario 12 de Octubre, Madrid

12:40 - 12:55 h Molecular classification in breast cancer Dra. Laura García Estévez, Hospital Universitario HM Sanchinarro-CIOCC,

Madrid


www.aseica.es


10

13:10 - 13:55 h RECENT ADVANCES IN PROSTATE CANCER Session supported by an educational grant

Chairpersons:

Dr. José Ángel Arranz, Hospital General Universitario Gregorio Marañón,

Madrid

Dr. Álvaro Aytes, Institut d’Investigació Biòmedica de Bellvitge-IDIBELL,

Barcelona

13:10 - 13:25 h Emerging therapeutic strategies Dr. Daniel Castellano, Hospital Universitario 12 de Octubre, Madrid

13:25 - 13:40 h Research advances towards disease eradication Dra. Rebeca Lozano, Centro Nacional de Investigaciones Oncológicas-CNIO,

Madrid


13:55 - 14:55 h POSTER VIEWING, NETWORKING AND LUNCH

14:55 - 15:40 h RECENT ADVANCES IN COLON CANCER

Chairpersons:

Dr. Eduardo Díaz-Rubio, Hospital Clínico San Carlos, Madrid

Dr. Antonio García de Herreros, Institut Hospital del Mar

d’Investigacions Mèdiques-IMIM, Barcelona

14:55 - 15:10 h Emerging therapeutic strategies Dra. Rocío García-Carbonero, Hospital Universitario 12 de Octubre, Madrid

15:10 - 15:25 h Research advances towards disease eradication Dr. Gabriel Capellà, Institut d’Investigació Biòmedica de Bellvitge-IDIBELL,

Barcelona


15:40 - 16:30 h THE NEW FRONTIER OF CANCER 15:40 - 15:45 h Chairperson: Dr. Joaquín Arribas, ICREA-Vall d’Hebron Institut d’Oncologia, Barcelona

15:45 - 16:25 h Speakers: A clinical vision:

Dr. Luis Paz-Ares, Hospital Universitario 12 de Octubre, Madrid

A biological vision:

Dr. Ángel Carracedo, Universidad de Santiago de Compostela





11

16:30 - 17:45 h 5th SESSION: RESEARCH AND DIAGNOSTIC PLATFORMS Chairpersons:

Dr. Jesús García-Foncillas, Hospital Universitario Fundación Jiménez

Díaz, Madrid

Dr. Fernando López-Ríos, Hospital Universitario HM Sanchinarro-CIOCC,

Madrid

16:30 - 16:45 h Precision medicine and Big Data Dr. Víctor Quesada, Universidad de Oviedo

16:45 - 17:00 h Delivering precision medicine in oncology today and in future Dr. Joan Albanell, Hospital del Mar - Parc de Salut Mar, Barcelona

17:00 - 17:15 h Patient-derived xenograft applications Dr. Alberto Villanueva, Hospital Duran i Reynals-ICO, Barcelona

17:15 - 17:20 h Oral communication New CRISPR/CAS9- based mouse model for the study of gliomas Dr. Álvaro Curiel, Centro Nacional de Investigaciones Oncológicas-CNIO,

Madrid

17:20 - 17:25 h Oral communication Multifunctional theranostic nanoemulsions for targeted imaging and drug delivery in metastatic cancer Dra. Sandra Díez, Fundación Ramón Domínguez, Santiago de Compostela


17:45 - 18:05 h AWARDS FOR THE BEST COMMUNICATIONS & CLOSING

18:05 - 18:35 h ASEICA ASSEMBLY (Only for ASEICA’s members)

www.aseica.es


12

General Information

VENUEAula Magna Facultad de MedicinaUniversidad Autónoma de Madrid • Campus de Medicina c/ Arzobispo Morcillo, 2-4 - 28029, Madrid

LANGUAGESMain languages: English and Spanish

CERTIFICATE OF ATTENDANCEIf you would like to receive the Certificate of Attendance, you must fill the form that can be found at the Technical Secretary during the event.

REGISTRATIONOnly proper accredited attendants will be able to access the venue; please, make sure your lanyard is visible all the time. The registration fee covers: access to all the scientific sessions, official documentation, certificate of attendance, coffee breaks and lunches.

Until 30th September

Until 31st October

On site

Students and Predocs Members 150 € 175 € 200 €

Students and Predocs non-members 300 € 350 € 400 €

Members ASEICA-ASPIC-EACR-SEOM-SEBBM-AECC-CERU

300 € 350 € 400 €

Members FESEO 500 € 550 € 650 €

Non-members 600 € 650 € 700 €

CIBERONC Member ASEICA 300 € 350 € 400 €

CIBERONC non-Member ASEICA 350 € 400 € 450 €

ACREDITATIONAccreditation requested to the Spanish System of Continuing Medical Education of the Community of Madrid. Attendance to the entire course is mandatory in order to obtain credits.



13

NOTES

www.aseica.es

14

NOTES



15

NOTES

www.aseica.es



Endorsed by:

1st aseica educational symposium - tacticsmd.net

Documents